Table 1 Clinicopathological characteristics of 80 invasive breast cancer patients
Characteristics | pBRE I-II Survivors ≥8years (n = 21) | pBRE III Survivors ≥8years (n = 19) | pBRE I-II Survivors < 8 years (n = 20) | pBRE III Survivors <8 years (n = 20) |
|---|---|---|---|---|
Mean age (y) | 58 (39–72) | 52 (27–7) | 55 (39–71) | 53 (33–72) |
Histologic type | ||||
Ductal | 15 (71) | 18 (95) | 15 (75) | 16 (80) |
Lobular | 2 (10) | 1 (5) | 4 (20) | 3 (15) |
Ductal + lobular | 0 (0) | 0 (0) | 1 (5) | 0 (0) |
Other | 3 (14) | 0 (0) | 0 (0) | 1 (5) |
Not available | 1 (5) | 0 (0) | 0 (0) | 0 (0) |
Pathologic tumor size (mm) | ||||
pT1 (0–20) | 2 (9) | 6 (32) | 3 (15) | 5 (25) |
pT2 (>20-50) | 18 (86) | 9 (47) | 16 (80) | 13 (65) |
pT3 (>50) | 1 (5) | 4 (21) | 1 (5) | 2 (10) |
pT4 | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
BRE grade | ||||
I-II | 21 (100) | 20 (100) | ||
III | 19 (100) | 20 (100) | ||
No. of axillary lymph nodes | ||||
0 | 7 (33) | 7 (37) | 7 (35) | 7 (35) |
1-3 | 5 (24) | 7 (37) | 6 (30) | 6 (30) |
≥4 | 9 (43) | 5 (26) | 7 (35) | 7 (35) |
Surgery | ||||
Lumpectomy | 9 (43) | 6 (32) | 9 (45) | 6 (30) |
Mastectomy | 12 (57) | 13 (68) | 11 (55) | 14 (70) |
ER/PR status | ||||
Negative | 11 (52) | 8 (42) | 13 (65) | 7 (35) |
Positive | 9 (43) | 11 (58) | 7 (35) | 13 (65) |
Not available | 1 (5) | |||
HER2/ neu status | ||||
Positive | 7 (33) | 8 (42) | 8 (40) | 3 (15) |
Negative | 11 (52) | 10 (53) | 11 (55) | 9 (45) |
Not available | 3 (15) | 1 (5) | 1 (5) | 8 (40) |